Published in Am J Respir Cell Mol Biol on August 01, 1994
Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice. Proc Natl Acad Sci U S A (1995) 3.08
Genetic disorders of surfactant dysfunction. Pediatr Dev Pathol (2009) 1.77
Interstitial lung disease in children -- genetic background and associated phenotypes. Respir Res (2005) 1.05
Pepsinogen C proteolytic processing of surfactant protein B. J Biol Chem (2008) 1.04
Diagnostic Pathology of Diffuse Lung Disease in Children. Pediatr Allergy Immunol Pulmonol (2010) 1.03
Surfactant phospholipid metabolism. Biochim Biophys Acta (2012) 1.03
Regulated gene expression in cultured type II cells of adult human lung. Am J Physiol Lung Cell Mol Physiol (2010) 1.02
Pulmonary pathology in thyroid transcription factor-1 deficiency syndrome. Am J Respir Crit Care Med (2010) 1.00
Direct simulation of protein-mediated vesicle fusion: lung surfactant protein B. Biophys J (2010) 0.89
Critical structure-function determinants within the N-terminal region of pulmonary surfactant protein SP-B. Biophys J (2005) 0.89
The pulmonary surfactant: impact of tobacco smoke and related compounds on surfactant and lung development. Tob Induc Dis (2004) 0.79
Disruption of sorting nexin 5 causes respiratory failure associated with undifferentiated alveolar epithelial type I cells in mice. PLoS One (2013) 0.75
When is an Alveolar Type 2 Cell an Alveolar Type 2 Cell? A Conundrum for Lung Stem Cell Biology and Regenerative Medicine. Am J Respir Cell Mol Biol (2017) 0.75
Nucleotide sequence of the AIDS virus, LAV. Cell (1985) 16.81
Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet (1993) 16.75
The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature (1992) 11.99
Nucleotide sequence of the visna lentivirus: relationship to the AIDS virus. Cell (1985) 7.86
A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med (2001) 4.68
Rapid Mycobacterium species assignment and unambiguous identification of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis by automated DNA sequencing. Arch Pathol Lab Med (1995) 4.10
Isolation of cDNA clones for the human complement protein factor B, a class III major histocompatibility complex gene product. Proc Natl Acad Sci U S A (1982) 3.89
Chance and consensus in peer review. Science (1981) 3.77
Sequence and comparative analysis of three Enterobacter cloacae ampC beta-lactamase genes and their products. Biochem J (1988) 3.66
Synthesis of the second component of complement by long-term primary cultures of human monocytes. J Exp Med (1976) 3.64
Plasma and cytoplasmic gelsolins are encoded by a single gene and contain a duplicated actin-binding domain. Nature (1986) 3.50
Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. N Engl J Med (1993) 3.33
Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis. Lancet (1985) 3.32
Inhibition of phagocytosis of complement C3- or immunoglobulin G-coated particles and of C3bi binding by monoclonal antibodies to a monocyte-granulocyte membrane glycoprotein (Mol). J Clin Invest (1983) 3.23
The challenge of tuberculosis: statements on global control and prevention. Lancet (1995) 3.19
Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression. J Clin Invest (1986) 3.05
Homozygous deficiency of C3 in a patient with repeated infections. Lancet (1972) 3.04
A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. J Clin Invest (1994) 2.98
Pretranslational modulation of acute phase hepatic protein synthesis by murine recombinant interleukin 1 (IL-1) and purified human IL-1. J Exp Med (1985) 2.84
Nuclear events of apoptosis in vitro in cell-free mitotic extracts: a model system for analysis of the active phase of apoptosis. J Cell Biol (1993) 2.48
Deficiency of a granulocyte-membrane glycoprotein (gp150) in a boy with recurrent bacterial infections. N Engl J Med (1982) 2.47
Cesarean section delivery in the 1980s: international comparison by indication. Am J Obstet Gynecol (1994) 2.45
Abrogation of the alternative complement pathway by targeted deletion of murine factor B. Proc Natl Acad Sci U S A (1997) 2.44
Biosynthesis of complement. Adv Immunol (1976) 2.36
Oxytocin receptor antagonists for inhibiting preterm labour. Cochrane Database Syst Rev (2005) 2.36
The disposition of voriconazole in mouse, rat, rabbit, guinea pig, dog, and human. Drug Metab Dispos (2003) 2.32
Temporary and permanent modifications to a single strain of mouse scrapie on transmission to rats and hamsters. J Gen Virol (1987) 2.27
Molecular map of the murine S region. Proc Natl Acad Sci U S A (1983) 2.24
Organization of repeated regions within the Epstein-Barr virus DNA molecule. J Virol (1980) 2.12
Polymorphism of the human complement C4 and steroid 21-hydroxylase genes. Restriction fragment length polymorphisms revealing structural deletions, homoduplications, and size variants. J Clin Invest (1986) 2.00
Screening for cystic fibrosis; public policy and personal choices. N Engl J Med (1990) 1.97
Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic expression of C3 mRNA. Immunopharmacology (1999) 1.94
Rheumatoid arthritis. Biosynthesis of complement proteins by synovial tissues. N Engl J Med (1974) 1.88
Is a rising caesarean section rate inevitable? Br J Obstet Gynaecol (1998) 1.87
Expression of the alpha 1-proteinase inhibitor gene in human monocytes and macrophages. Proc Natl Acad Sci U S A (1985) 1.85
Use of a cDNA clone for the fourth component of human complement (C4) for analysis of a genetic deficiency of C4 in guinea pig. Proc Natl Acad Sci U S A (1983) 1.82
Cell-free synthesis of the fourth component of guinea pig complement (C4): identification of a precursor of serum C4 (pro-C4). Proc Natl Acad Sci U S A (1977) 1.79
Scientific output and recognition: a study in the operation of the reward system in science. Am Sociol Rev (1967) 1.78
Complement biosynthesis by the human hepatoma-derived cell line HepG2. J Clin Invest (1982) 1.75
Autophagic vacuoles in experimental atrophy. Exp Mol Pathol (1971) 1.75
Spina bifida and anencephaly in Scotland. Br Med J (Clin Res Ed) (1984) 1.75
Genetic defect in secretion of complement C5 in mice. Nature (1979) 1.68
gamma-Interferon increases expression of class III complement genes C2 and factor B in human monocytes and in murine fibroblasts transfected with human C2 and factor B genes. J Biol Chem (1985) 1.67
Regulation of class III major histocompatibility complex gene products by interleukin-1. Science (1986) 1.65
Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression. J Clin Invest (1997) 1.62
Local extrahepatic expression of complement genes C3, factor B, C2, and C4 is increased in murine lupus nephritis. J Clin Invest (1988) 1.60
Cloning, sequencing, and expression of the apa gene coding for the Mycobacterium tuberculosis 45/47-kilodalton secreted antigen complex. Infect Immun (1995) 1.60
Immune hemolysis and the functional properties of the second (C2) and fourth (C4) components of complement. 3. The hemolytic efficiency of human and guinea pig C2 and C4. J Immunol (1971) 1.60
Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B. J Immunol (2000) 1.55
Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis. N Engl J Med (1985) 1.55
Characterization of the human complement (c3b) receptor with a fluid phase C3b dimer. J Immunol (1981) 1.55
Direct vesicoureteral scintigraphy: quantifying early outcome predictors in children with primary reflux. J Nucl Med (1994) 1.52
The cellular defect in alpha 1-proteinase inhibitor (alpha 1-PI) deficiency is expressed in human monocytes and in Xenopus oocytes injected with human liver mRNA. Proc Natl Acad Sci U S A (1985) 1.51
Human serum amyloid A (SAA): biosynthesis and postsynthetic processing of preSAA and structural variants defined by complementary DNA. Biochemistry (1985) 1.49
Progression of cystic fibrosis lung disease as a function of serum immunoglobulin G levels: a 5-year longitudinal study. J Pediatr (1984) 1.48
Human factor H deficiency. Mutations in framework cysteine residues and block in H protein secretion and intracellular catabolism. J Biol Chem (1997) 1.48
Human serum amyloid P component. cDNA isolation, complete sequence of pre-serum amyloid P component, and localization of the gene to chromosome 1. J Biol Chem (1985) 1.47
Difference in direct charge-parity violation between charged and neutral B meson decays. Nature (2008) 1.46
Ontogeny of the human complement system: in vitro biosynthesis of individual complement components by fetal tissues. J Clin Invest (1972) 1.45
Procedure guideline for radionuclide cystography in children. Society of Nuclear Medicine. J Nucl Med (1997) 1.45
Synthesis of the first component of human complement in vitro. J Exp Med (1968) 1.44
Production of the second (C2) and fourth (C4) components of guinea pig complement by single peritoneal cells: evidence that one cell may produce both components. J Immunol (1972) 1.44
Tissue-specific pretranslational regulation of complement production in human mononuclear phagocytes. J Immunol (1985) 1.43
The Ortega Hypothesis: Citation analysis suggests that only a few scientists contribute to scientific progress. Science (1972) 1.42
Langerhans cell histiocytosis: presentation and evolution of radiologic findings with clinical correlation. Radiographics (1995) 1.41
Type I human complement C2 deficiency. A 28-base pair gene deletion causes skipping of exon 6 during RNA splicing. J Biol Chem (1992) 1.40
Isolation of a cDNA clone encoding a high molecular weight precursor to a 6-kDa pulmonary surfactant-associated protein. J Biol Chem (1987) 1.40
Hypogammaglobulinemia in patients with cystic fibrosis. N Engl J Med (1980) 1.40
Malfunctioning gas scavenging unit. Anaesthesia (2007) 1.38
Ventilation/perfusion mismatch caused by positive pressure ventilatory support. J Nucl Med (1989) 1.37
Low ionic strength or chemical cross-linking of monomeric C3b increases its binding affinity to the human complement C3b receptor. Immunology (1983) 1.35
Cyclo-oxygenase (COX) inhibitors for treating preterm labour. Cochrane Database Syst Rev (2005) 1.35
Spatial learning as an adaptation in hummingbirds. Science (1982) 1.33
Expression and regulation of the murine serum amyloid A (SAA) gene in extrahepatic sites. J Immunol (1985) 1.33
Biosynthesis and processing of a human precursor complement protein, pro-C3, in a hepatoma-derived cell line. Science (1982) 1.31
Molecular and phenotypic variability in the congenital alveolar proteinosis syndrome associated with inherited surfactant protein B deficiency. J Pediatr (1994) 1.30
In vitro synthesis of the first component of complement by guinea pig small intestine. Proc Natl Acad Sci U S A (1966) 1.30
Human SP-A protein variants derived from one or both genes stimulate TNF-alpha production in the THP-1 cell line. Am J Physiol Lung Cell Mol Physiol (2000) 1.29
Syrian hamster female protein: analysis of female protein primary structure and gene expression. Science (1985) 1.28
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Biosynthetic defect in monocytes from human beings with genetic deficiency of the second component of complement. N Engl J Med (1975) 1.27
Biosynthesis of the third component of complement (C3) in vitro by monocytes from both normal and homozygous C3-deficient humans. J Clin Invest (1977) 1.26
Purification of the first component of complement by zonal ultracentrifugation. J Immunol (1969) 1.26
Biosynthesis of complement components. Fed Proc (1981) 1.25
The C'la fixation and transfer test: examples of its applicability to the detection and enumeration of antigens and antibodies at cell surfaces. J Immunol (1968) 1.25
Biosynthesis of the second (C2) and fourth (C4) components of complement in vitro by tissues isolated from guinea-pigs with genetically determined C4 deficiency. Immunology (1972) 1.24
Phylogenetic conservation of a class III major histocompatibility complex antigen, factor B. Isolation and nucleotide sequencing of mouse factor B cDNA clones. J Biol Chem (1983) 1.23
Homozygous human C3 deficiency. The role of C3 in antibody production, C-1s-induced vasopermeability, and cobra venom-induced passive hemolysis. J Clin Invest (1976) 1.23
Biosynthesis of pro-C3, a precursor of the third component of complement. J Exp Med (1977) 1.23
Structure of a human serum amyloid A gene and modulation of its expression in transfected L cells. J Biol Chem (1987) 1.22
The human C-reactive protein gene (CRP) and serum amyloid P component gene (APCS) are located on the proximal long arm of chromosome 1. Immunogenetics (1986) 1.21
Histaminase release from human eosinophils. J Immunol (1977) 1.21
Complementary DNA and derived amino acid sequence of the alpha subunit of human complement protein C8: evidence for the existence of a separate alpha subunit messenger RNA. Biochemistry (1987) 1.20
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Synthesis of the first component of guinea pig complement by columnar epithelial cells of the small intestine. J Immunol (1968) 1.19
Molecular regulation of MHC class III (C4 and factor B) gene expression in mouse peritoneal macrophages. J Immunol (1984) 1.19
DNA polymorphism of the C4 genes. A new marker for analysis of the major histocompatibility complex. N Engl J Med (1984) 1.19
The use of single photon emission computed tomography (SPECT) in the diagnosis of low-back pain in young patients. Spine (Phila Pa 1976) (1988) 1.18
Complement biosynthesis in human breast-milk macrophages and blood monocytes. Immunology (1982) 1.17